Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2017-02-13
2017-06-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Quinoa is a traditional Andean seed crop consumed in a similar fashion to staple cereal grains in Europe, and the popularity of quinoa has been growing worldwide because of its nutritional content and perceived healthiness. Quinoa contains a small amount of fat, but the ratio of omega-6 and omega-3 essential fats is more favourable in quinoa than in other plant oils. An opportunity therefore exists to incorporate quinoa flour into more frequently consumed food products (e.g. biscuits) as an alternative means of increasing consumers omega-3 intake.
The purpose of this study is to investigate the effect of consuming quinoa-enriched biscuits, compared to control, on markers of CVD risk over 4-weeks in older adults.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quinoa Biscuit
The quinoa-enriched biscuits containing 7.11g quinoa flour.
Quinoa biscuit
2x15g biscuits per day for 28 consecutive days (4 weeks).
Control biscuit
The placebo control biscuit: an iso-energetic, matched product in terms of appearance, taste, texture and smell.
Control biscuit
2x15g biscuits per day for 28 consecutive days (4 weeks).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quinoa biscuit
2x15g biscuits per day for 28 consecutive days (4 weeks).
Control biscuit
2x15g biscuits per day for 28 consecutive days (4 weeks).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 50-75 years at recruitment
* Low fish consumers (\<2 servings/wk)
* Non-smokers
* Not regularly consuming plant stanols
Exclusion Criteria
* Aged \<50 or \>75 years at recruitment
* Fish consumers (2 servings/wk or more)
* Current smokers
* Pregnant/lactating females
* Coeliac disease, wheat intolerance or any other food allergy or intolerance that would prevent consumption of the biscuits
* Currently taking any fish oil-containing supplement
* Diagnosed with a chronic medical condition (such as diabetes; CVD autoimmune/ inflammatory disorders; cancer)
* Prescribed cholesterol or blood pressure lowering medications
* Daily consumption of plant stanols
50 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Regional Centre for Studies in Food and Health (CREAS), Valparaíso, Chile
UNKNOWN
University of Ulster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Intervention Studies Unit, Ulster University
Coleraine, Londonderry, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pourshahidi LK, Caballero E, Osses A, Hyland BW, Ternan NG, Gill CIR. Modest improvement in CVD risk markers in older adults following quinoa (Chenopodium quinoa Willd.) consumption: a randomized-controlled crossover study with a novel food product. Eur J Nutr. 2020 Oct;59(7):3313-3323. doi: 10.1007/s00394-019-02169-0. Epub 2020 Jan 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UREC/16/0106
Identifier Type: -
Identifier Source: org_study_id